Investigational Therapies for the Treatment of COVID-19: Updates from Ongoing Clinical Trials

Eur Urol Focus. 2020 Sep 15;6(5):1028-1031. doi: 10.1016/j.euf.2020.05.019. Epub 2020 Jun 5.

Authors

Alexandra Abrams-Downey¹, Joseph Saabiye², Monica Vidaurrazaga²

Affiliations

¹ Icahn School of Medicine at Mount Sinai, Division of Infectious Diseases, New York, NY, USA. Electronic address: alexandra.abrams-downey@mssm.edu.
² Icahn School of Medicine at Mount Sinai, Division of Infectious Diseases, New York, NY, USA.

No abstract available

Publication types

Review

MeSH terms

Adenosine Monophosphate / analogs & derivatives
Adenosine Monophosphate / therapeutic use
Alanine / analogs & derivatives
Alanine / therapeutic use
Antibodies, Monoclonal, Humanized / therapeutic use
Antirheumatic Agents / therapeutic use*
Antiviral Agents / therapeutic use*
Betacoronavirus
COVID-19
COVID-19 Drug Treatment
COVID-19 Serotherapy
Chloroquine / therapeutic use
Clinical Trials as Topic
Coronavirus Infections / drug therapy
Coronavirus Infections / therapy*
Humans
Hydroxychloroquine / therapeutic use
Immunization, Passive / methods
Immunologic Factors / therapeutic use*
Pandemics
Pneumonia, Viral / therapy*
Receptors, Interleukin-6 / antagonists & inhibitors
SARS-CoV-2

Substances

Antibodies, Monoclonal, Humanized
Antirheumatic Agents
Antiviral Agents
Immunologic Factors
Receptors, Interleukin-6
remdesivir
Adenosine Monophosphate
Hydroxychloroquine
Chloroquine
tocilizumab
sarilumab
Alanine